Lead-inhibited adenylate cyclase: a model for the evaluation of chelating agents in the treatment of cns lead toxicity.
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001921:Brain / Q000201:enzymology*; D001927:Brain Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology; D002525:Cerebellar Cortex / Q000187:drug effects / Q000201:enzymology; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D066298:In Vitro Techniques; D007854:Lead / Q000009:adverse effects / Q000494:pharmacology*; D008297:Male; D051381:Rats
D000067956:Adenylyl Cyclase Inhibitors; D002614:Chelating Agents; D007854:Lead